Replies to post #4405 on Moderna Inc (MRNA)

[Tha Part Time Er]

July 27 (Reuters) - Moderna Inc said on Monday it has started a U.S. government-backed late-stage trial evaluating its COVID-19 vaccine candidate, mRNA-1273, in about 30,000 adults who do not have the respiratory illness caused by the new coronavirus.

The main goal of the study will be prevention of the symptomatic COVID-19 disease, the company said. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)

[Pedro2004]

By all means...buy as many shares as you can at these prices.

But keep in mind the Insiders are dumping shares as quickly as they can issue themselves shares.